Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
Supplement: Circumventing Cancer Cells’ Defenses
Cancer Cells Can Exploit Well-Evolved Moves to Evade Immune Detection
Smelly Camel Urine Finding Could Lead to Novel Therapies for Sleeping Sickness
Sounds of Science Podcast
Supplement: Treating “Solid” Tumors with CAR T Cells
The Road to Developing Effective Cancer Immunotherapies Using CAR T Cells Has Been a Long and Sometimes Rocky One
For full access to this article login to GEN Select now.
New Biomanufacturing Opportunities & Challenges
Recent Trends in Outsourcing, Disposables, and Systems for High Expression of Products
- The market in biologics could be worth $3.5 billion by 2010, with opportunities offered both by new biopharmaceuticals and old ones coming off patent, said consultant Monica Darnborough, Ph.D., formerly head of the U.K. government's bioscience unit. Addressing the "BioLogic Europe" conference held in Geneva recently, she added that, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.